Weigao’s Dialysis Business Seeks Hong Kong IPO in MedTech Boom
Shandong Weigao Group's blood purification business has applied to list on the Hong Kong Stock Exchange, aiming to become the group’s fourth listed company Key Takeaways: Weigao Blood Purification filed…
Recent Articles
RELATED ARTICLES
-
Shandong Fengxiang falls afoul of sagging poultry prices
9977.HK - CHINA BULLETIN: Blinken, Yellen Talk Up China Challenge
- Payment app Lianlian seeks IPO relief from cash crunch
-
Venus Medtech still seeking cure for governance problems
2500.HK
- Baiwang eyes Hong Kong IPO to support its money-hungry loan facilitation business
- Lopal Tech seeks cash after losses balloon with lithium price plunge
- CHINA BULLETIN: Manufacturing Déjà Vu
